![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/34fd32696f2b1472725b338fc204d29585f2fe93/5-Figure2-1.png)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar
![The use of prostate specific antigen density to predict clinically significant prostate cancer | Scientific Reports The use of prostate specific antigen density to predict clinically significant prostate cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-76786-9/MediaObjects/41598_2020_76786_Fig1_HTML.png)
The use of prostate specific antigen density to predict clinically significant prostate cancer | Scientific Reports
![A predictive model for prostate cancer incorporating PSA molecular forms and age | Scientific Reports A predictive model for prostate cancer incorporating PSA molecular forms and age | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-58836-4/MediaObjects/41598_2020_58836_Fig1_HTML.png)
A predictive model for prostate cancer incorporating PSA molecular forms and age | Scientific Reports
![Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels | Prostate Cancer and Prostatic Diseases Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.pcan.4500957/MediaObjects/41391_2007_Article_BF4500957_Fig1_HTML.jpg)
Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels | Prostate Cancer and Prostatic Diseases
![A calculator based on prostate imaging reporting and data system version 2 (PI-RADS V2) is a promising prostate cancer predictor | Scientific Reports A calculator based on prostate imaging reporting and data system version 2 (PI-RADS V2) is a promising prostate cancer predictor | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-43427-9/MediaObjects/41598_2019_43427_Fig1_HTML.png)